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associated with mortality rates independent of hospital volume. Given
these results, further research into what components of hospital-based
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Abstract:We examinedwhether the level of hospital-based healthcare
technology was related to the 30-day postoperative mortality rates, after
adjusting for hospital volume, of ischemic stroke patients who under-
went a cerebrovascular surgical procedure.
Using the National Health Insurance Service-Cohort Sample Data-
base, we reviewed records from 2002 to 2013 for data on patients with
ischemic stroke who underwent cerebrovascular surgical procedures.
Statistical analysis was performed using Cox proportional hazard
models to test our hypothesis.
A total of 798 subjects were included in our study. After adjusting
for hospital volume of cerebrovascular surgical procedures as well as all
for other potential confounders, the hazard ratio (HR) of 30-day
mortality in low healthcare technology hospitals as compared to high
healthcare technology hospitals was 2.583 (P < 0.001). We also found
that, although the HR of 30-day mortality in low healthcare technology
hospitals with high volume as compared to high healthcare technology
hospitals with high volume was the highest (10.014, P < 0.0001),
cerebrovascular surgical procedure patients treated in low healthcare
technology hospitals had the highest 30-day mortality rate, irrespective
of hospital volume.
Although results of our study provide scientific evidence for a
hospital volume/30-day mortality rate relationship in ischemic stroke
patients who underwent cerebrovascular surgical procedures, our results
also suggest that the level of hospital-based healthcare technology is, PhD, Sang Gyu L PhD,
ung-In Jang, MD, PhD
(Medicine 95(11):e3035)
Abbreviations: HR = Hazard Ratio, ICD-10 = International
Classification of Diseases, 10th Revision, IRB = Institutional
Review Board, MRIm = agnetic resonance imaging, NHIS-CSD =
National Health Insurance Service-Cohort Sample Data, PCCLp =
atient clinical complexity level.
INTRODUCTION
C erebrovascular disease is a major cause of disability anddeath and is high-risk, requiring safe practices and
advanced medical techniques for diagnosis and treatment.
Accurate assessment of hospital performance for surgical pro-
cedures has become increasingly important since the imple-
mentation of pay-for-performance programs designed to link
payments to clinical outcomes and public reporting of assessment
results.1,2 Thus, the success of quality improvement programs,
such as pay-for-performance programs, in improving surgical
outcomes is based on accurate performance assessments and the
ability to identify truly high-performing hospitals.
One of the most simple and easily available performance
measures in surgery is the surgical procedure volume of a
hospital based on the intuitively attractive ‘‘more is better’’
concept. Considerable evidence exists that higher hospital
surgical volume is associated with improved clinical outcomes
such as operative mortality,3 length of stay, cost,4 and survival.3
Despite these observations, since the majority of peer-
reviewed literature is primarily aimed at determining the pre-
sence of the volume–outcome relationships for various pro-
cedures, the true mechanism of the volume–outcome
association remains in dispute. For example, the magnitude
of the volume–outcome relationship varies according to the
technical difficulty of the surgery and the availability of specific
healthcare technology.5 Evidence from qualitative studies6
suggests that hospital volume reflects hospital characteristics,
such as technical capabilities, personalities of the physicians or
staff, culture, leadership, structure, strategy, information, com-
munication pathways, skills training, and physician engage-
ment. These contributors to hospital volume may partially
explain the relationship between volume and outcomes. How-
ever, they do not fully reveal what volume is a proxy for.
It is also possible that, as prior evidence7 has demonstrated,
high healthcare technology is associated with lower mortality
rates and the improved outcomes are derived from the range of
critical care and treatment services offered in high healthcareCharacteristics of high healthcare
ay also include availability of new tech-
ed operating rooms, better management
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of health resources, well selected care teams, advanced training
programs,multidisciplinary discussions, improveddecisionmak-
ing and care, use of standardized management protocols, and
appropriate mechanisms to improve treatment that may affect
postoperative outcomes.8–10
As a result, the use of surgical volume as a meaningful
quality indicator and predictor for outcomes in hospital care is
questionable. High healthcare technology may be a better
surrogate for hospital healthcare quality. A variety of models
for measuring hospital-based healthcare technology have been
proposed,11,12 although the accuracy of these models in pre-
dicting outcomes is still unclear. However, practical application
of these models is limited because of their complexity. A simple
and intuitive method to capture hospital-based healthcare tech-
nology and to understand what can serve as a proxy for
healthcare quality is desired. Thus, based on recently published
novel but simple and intuitive methods13 and using current
nationwide cohort data from 2002 to 2013, we investigated
whether the level of hospital-based healthcare technology was
related to 30-day, postoperative mortality rates in ischemic
stroke patients who underwent cerebrovascular-related surgery
after adjusting for hospital procedure volume.
METHODS
Data Sources and Study Design
This study used the National Health Insurance Service-
Cohort Sample Data (NHIS-CSD) from 2002 to 2013, which
were released by the Korean National Health Insurance Service.
Initial cohort members were selected by stratified random
sampling using a systematic method to generate a representative
sample of the 46,605,433 Korean residents recorded in 2002.
Those individuals were followed through 2013. The number of
initial cohort members was 1,025,340, approximately 2.2% of
the Korean population in 2002.
The healthcare utilization claims data include information
on prescription drugs, medical procedures, diagnostic codes
based on the International Classification of Diseases, 10th
Revision (ICD-10), and healthcare costs. If a member was
censored due to death or emigration, a new member was
recruited among newborns of the same calendar birth year of
the censored member.
We analyzed a unique database of representative individ-
uals who had an ischemic stroke and underwent a cerebro-
vascular-related surgical procedure. To select our study
participants from the NHIS-CSD, we used the ICD-10 code
with I63.0 to I63.9 for main diagnosis and further limited the
search to include only patients who had a cerebrovascular-
related surgical procedure, such as craniotomy for evacuation
of a hematoma or craniotomy or craniectomy for decompres-
sion. We linked each ischemic stroke patient using a license
number to a separate hospital licensure database that included
the calendar years. Linking the selected patients to the hospital
allowed us to study the association of hospital-based healthcare
technology and outcomes during the 12-year follow-up period.
This study was approved by the Institutional Review Board
of Yonsei University Graduate School of Public Health (2-
1040939-AB-N-01-2016-104).
Study Variables
Kim et alIndependent Variables
For each hospital, the volume of patients undergoing
cerebrovascular surgery per year was ranked from low to high
2 | www.md-journal.comusing the Rank function provided in SAS software (SAS
Institute Inc., Cary, NC; for use in Model 1). We also
measured levels of hospital-based healthcare technology
implementation based on a range of diagnostic codes for
ischemic stroke (ICD-10 codes) recorded over the study
period; levels of hospital-based healthcare technology were
also ranked from low to high using the SAS Rank function (for
use in Model 2). In Models 1 and 2, the volumes of cerebro-
vascular-related surgical patients and the levels of hospital-
based healthcare technology were categorized as low, med-
ium, and high to assess their respective effects on 30-day all-
cause mortality. Finally, 9 additional groups (listed in Table 1)
were devised to assess the combined effects of healthcare
technology and volume of cerebrovascular surgeries on 30-
day all-cause mortality (Model 3).
Dependent Variables
In this study, the primary end point was 30-day, all-cause
mortality after the cerebrovascular-related surgical procedure.
Control Variables
Individual characteristics, such as age, sex, and residential
region, and hospital characteristics, including hospital type,
organization type, region, number of beds, number of doctors,
and magnetic resonance imaging (MRI) capabilities, were
included as variables that could affect the mortality in the
analysis. All covariates were categorical. To adjust for each
patient’s clinical severity, patient clinical complexity level
(PCCL), inpatient type, diagnosis code, and type of procedure
were also included in individual characteristics analyzed. Age
groups were divided into 5 categories: 39, 40 to 49, 50 to 59,
60 to 69, and 70. Patient residential regions and hospital
regions were categorized as metropolitan (Seoul), urban (Dae-
jeon, Daegu, Busan, Incheon, Kwangju, or Ulsan), or rural (not
classified as a metropolitan or urban).
Statistical Analysis
The primary analysis was based on Cox proportional
hazard models. Survival time was defined as the time between
30 days following the cerebrovascular surgical procedure and
the date of death. The Kaplan–Meier method was used to plot
crude survival curves according to time following cerebro-
vascular surgical procedure. We plotted a survival curve for
mortality and a cumulative curve for 30-day mortality. Con-
sidering that critical illness has an effect on outcomes, the
Cox proportional hazard model, which is the most frequently
used model, might be accurate because it relies on the
assumption that the prognostic factors have constant hazard
ratios (HRs) over time. For all analyses, the criterion for
significance was P  0.05, 2-tailed. All analyses were con-
ducted using the SAS statistical software package, version 9.4
(SAS Institute Inc.).
RESULTS
Prevalence of 30-Day, All-Cause Morality
In the 798 research subjects included in our study, the
prevalence of 30-day mortality was 10.03% (80 participants;
Table 1). Of the total sample, 13.5% of patients with 30-day
mortality were treated in low healthcare technology hospitals
Medicine  Volume 95, Number 11, March 2016per year, and 12.0% of patients with 30-day mortality were
treated in hospitals with low volume of cerebrovascular surgical
procedures per year (Table 1 and Figures 1–3).
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. General Baseline Characteristics of Hospitals and Subjects Included in the Analysis
Total 30-d, All-Cause Mortality
N % Alive % Dead % P Value
Hospital-based healthcare technology 0.335
Low 119 14.9 103 86.6 16 13.5
Middle 241 30.2 216 89.6 25 10.4
High 438 54.9 399 91.1 39 8.9
Hospital volume of cerebrovascular surgery 0.195
Low 276 34.6 243 88.0 33 12.0
Middle 264 33.1 236 89.4 28 10.6
High 258 32.3 239 92.6 19 7.4
Hospital-based healthcare technology–hospital
volume of cerebrovascular surgery
0.014
Low–low 64 8.0 56 87.5 8 12.5
Low–middle 42 5.3 39 92.9 3 7.1
Low–high 13 1.6 8 61.5 5 38.5
Middle–low 117 14.7 102 87.2 15 12.8
Middle–middle 71 8.9 64 90.1 7 9.9
Middle–high 53 6.6 50 94.3 3 5.7
High–low 95 11.9 85 89.5 10 10.5
High–middle 151 18.9 133 88.1 18 11.9
High–high 192 24.1 181 94.3 11 5.7
Individual
Sex 0.036
Male 476 59.7 437 91.8 39 8.2
Female 322 40.4 281 87.3 41 12.7
Age 0.021
39 41 5.1 40 97.6 1 2.4
40–49 43 5.4 34 79.1 9 20.9
50–59 115 14.4 109 94.8 6 5.2
60–69 231 29.0 206 89.2 25 10.8
70 368 46.1 329 89.4 39 10.6
Residential region 0.256
Metropolitan 154 19.3 144 93.5 10 6.5
Urban 203 25.4 182 89.7 21 10.3
Rural 441 55.3 392 88.9 49 11.1
PCCL 0.434
0 229 28.7 211 92.1 18 7.9
1 174 21.8 155 89.1 19 10.9
2 395 49.5 352 89.1 43 10.9
Inpatient type 0.152
Emergency room 500 62.7 444 88.8 56 11.2
Outpatient department 298 37.3 274 92.0 24 8.1
Type of procedure <0.0001
Craniotomy for evacuation of hematoma 40 5.0 35 87.5 5 12.5
Percutaneous transluminal angioplasty (cerebral) 46 5.8 45 97.8 1 2.2
Percutaneous intravascular installation of
metallic stent (cerebral)
209 26.2 199 95.2 10 4.8
Thrombolytic treatment (cerebral) 285 35.7 251 88.1 34 11.9
Embolization (cerebral) 12 1.5 10 83.3 2 16.7
Craniotomy or craniectomy for decompression 111 13.9 85 76.6 26 23.4
Others

95 11.9 93 97.9 2 2.1
Hospital
Type 0.293
General hospital 722 90.5 647 89.6 75 10.4
Hospital 76 9.5 71 93.4 5 6.6
Organization type 0.565
Public 17 2.1 16 94.1 1 5.9
Private 781 97.9 702 89.9 79 10.1
Medicine  Volume 95, Number 11, March 2016 Healthcare Technology and Quality
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved. www.md-journal.com | 3
Total 30-d, All-Cause Mortality
N % Alive % Dead % P Value
Region 0.114
Metropolitan 206 25.8 193 93.7 13 6.3
Urban 284 35.6 253 89.1 31 10.9
Rural 308 38.6 272 88.3 36 11.7
Beds 0.988
499 154 19.3 139 90.3 15 9.7
500–699 102 12.8 92 90.2 10 9.8
700–899 100 12.5 89 89.0 11 11.0
900 442 55.4 398 90.1 44 10.0
Doctors 0.667
99 205 25.7 185 90.2 20 9.8
100–199 98 12.3 90 91.8 8 8.2
200–299 133 16.7 116 87.2 17 12.8
300 362 45.4 327 90.3 35 9.7
MRI 0.553
No 41 5.1 38 92.7 3 7.3
Yes 757 94.9 680 89.8 77 10.2
Total 798 100.0 718 90.0 80 10.03
xity
ll b
TABLE 1. (Continued )
Kim et al Medicine  Volume 95, Number 11, March 2016Association Between Hospital-Based Healthcare
Technology and 30-Day Mortality
Table 2 shows the risk analysis with adjustments for age,
sex, residential region, PCCL, inpatient type, type of surgery,
hospital type, organization type, hospital region, number of
beds, number of doctors, andMRI capability. After adjusting for
all of these confounders, the HR of 30-day mortality in hospitals
with low volume (Model 1) was 1.700 (P ¼ 0.043) compared to
that in hospitals with high volume. After adjusting for hospital
volume of cerebrovascular surgical procedures as well as the
MRI¼magnetic resonance imaging, PCCL¼ patient clinical comple
Operation of cerebral arteriovenous malformation, operation of skuother confounders, the HR of 30-day mortality in low healthcare
technology hospitals (Model 2) was 2.583 (P ¼ 0.001) com-
pared to that in hospitals with high healthcare technology.
FIGURE 1. Hospital-based healthcare technology and 30-d, all-cause
4 | www.md-journal.comModel 3 examined the combined effects of hospital-based
healthcare technology and hospital volume of cerebrovascular
surgical procedures as well as the confounders. The HR of 30-
day mortality in low healthcare technology hospitals with low
volume (low–low) was 3.644 (P¼ 0.004) compared to that in
hospitals with high healthcare technology and high volume
(high–high; Figure 4). Interestingly, the HR of 30-day mortality
in low healthcare technology hospitals with high volume (low–
high) as compared to high healthcare technology hospitals with
high volume (high–high) was the highest (HR: 10.014, P <
level.
ase, carotid artery ligation, endoscopic brain surgery.0.0001).
Overall, we found that greater implementation of
healthcare technology, regardless of the volume of
mortality.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
all-
Medicine  Volume 95, Number 11, March 2016 Healthcare Technology and Qualitycerebrovascular-related surgical procedures performed, had a
marked effect on 30-day mortality rate. The HR of 30-day
mortality was the highest for low–high hospitals, while
high–high hospitals showed the lowest 30-day mortality rate.
Table 3 comprises results from subgroup analysis of
patients who underwent cerebrovascular-related procedures
and were admitted through the emergency room, after adjusting
for confounders. The subgroups analysis results seemed to show
a stronger relationship between hospital-based healthcare tech-
nology and volume of cerebrovascular-related surgeries. Never-
theless, the results showed a similar trend comparable to the
results for all cerebrovascular-related procedures (Figure 5).
FIGURE 2. Hospital volume of cerebrovascular surgery and 30-d,DISCUSSION
In this study, our primary purpose was to investigate
whether hospital-based healthcare technology was responsible
FIGURE 3. Combined variable analysis between hospital-based healt
and 30-d, all-cause mortality.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.for the observed volume–outcome relationship by examining
30-day postoperative mortality rates after adjusting for hospital
volume of cerebrovascular-related surgical procedures as well
as other covariates in longitudinal models using nationally
representative cohort data from 2002 to 2013 in South Korea.
The major findings of our study are as follows: hospital-based
healthcare technology has a substantial effect on 30-day post-
operative mortality among patients diagnosed with ischemic
stroke who underwent a surgical procedure (Model 2), although
hospital volume of cerebrovascular surgical procedure is also
related to 30-day postoperative mortality (Model 1). That is,
increased healthcare technology was associated with signifi-
cantly lower mortality rates, independent of the hospital volume
cause mortality.of cerebrovascular surgical procedures. Even after adjusting for
the comprehensive array of hospital characteristics such as
hospital type, number of beds, number of doctors, etc., mortality
hcare technology and hospital volume of cerebrovascular surgery
www.md-journal.com | 5
TABLE 2. Adjusted Association Between Hospital-Based Healthcare Technology and All-Cause Mortality
30-d, All-Cause Mortality
Model 1 Model 2 Model 3
HR SE P Value HR SE P Value HR SE P Value
Hospital-based healthcare technology
Low 2.583 0.292 0.001
Middle 1.534 0.226 0.059
High 1.000
Hospital volume of cerebrovascular surgery
Low 1.700 0.262 0.043 1.383 0.271 0.231
Middle 1.526 0.250 0.091 1.383 0.252 0.198
High 1.000 1.000
Hospital-based healthcare technology–hospital volume of cerebrovascular surgery
Low–low 3.644 0.447 0.004
Middle–low 3.269 0.363 0.001
High–low 1.327 0.422 0.502
Low–middle 2.244 0.578 0.162
Middle–middle 2.209 0.401 0.048
High–middle 2.196 0.343 0.022
Low–high 10.014 0.468 <0.0001




Male 0.794 0.209 0.269 0.774 0.209 0.222 0.774 0.213 0.229
Female 1.000 1.000 1.000
Age
39 1.000 1.000 1.000
40–49 14.509 1.083 0.014 16.509 1.089 0.010 16.197 1.100 0.011
50–59 3.488 1.122 0.266 4.166 1.130 0.207 3.926 1.136 0.229
60–69 11.380 1.067 0.023 12.167 1.077 0.020 12.313 1.085 0.021
70 9.016 1.062 0.038 9.745 1.074 0.034 8.755 1.081 0.045
Residential region
Metropolitan 0.719 0.439 0.453 0.730 0.429 0.463 0.687 0.446 0.401
Urban 0.724 0.279 0.248 0.670 0.278 0.150 0.581 0.291 0.062
Rural 1.000 1.000 1.000
PCCL
0 1.000 1.000 1.000
1 1.123 0.289 0.688 1.211 0.293 0.513 1.206 0.296 0.527
2 1.263 0.236 0.323 1.406 0.241 0.159 1.288 0.246 0.302
Inpatient type
Emergency room 1.174 0.104 0.122 1.308 0.244 0.272 1.277 0.248 0.323
Outpatient department 1.000 1.000 1.000
Type of procedure
Craniotomy for evacuation of hematoma 25.973 0.836 <0.0001 30.206 0.837 <0.0001 32.300 0.851 <0.0001
Percutaneous transluminal angioplasty (cerebral) 1.759 1.008 0.575 1.993 1.012 0.496 2.027 1.014 0.486
Percutaneous intravascular installation
of metallic stent (cerebral)
3.833 0.752 0.074 4.037 0.756 0.065 4.091 0.755 0.062
Thrombolytic treatment (cerebral) 7.651 0.731 0.005 8.215 0.734 0.004 8.012 0.734 0.005
Embolization (cerebral) 12.060 1.014 0.014 13.518 1.019 0.011 14.498 1.026 0.009






General hospital 1.657 0.776 0.515 2.182 0.789 0.323 1.941 0.803 0.409
Hospital 1.000 1.000 1.000
Organization type
Public 1.000 1.000 1.000
Private 1.162 1.033 0.884 0.939 1.038 0.952 1.057 1.041 0.958
Kim et al Medicine  Volume 95, Number 11, March 2016
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30-d, All-Cause Mortality
Model 1 Model 2 Model 3
HR SE P Value HR SE P Value HR SE P Value
Region
Metropolitan 0.602 0.425 0.232 0.527 0.416 0.124 0.571 0.427 0.189
Urban 1.551 0.279 0.115 1.431 0.277 0.197 1.620 0.283 0.089
Rural 1.000 1.000 1.000
Beds
499 1.191 0.561 0.755 1.057 0.566 0.921 1.048 0.576 0.935
500–699 1.433 0.419 0.390 1.405 0.419 0.417 1.395 0.428 0.436
700–899 1.212 0.331 0.561 1.236 0.328 0.518 1.284 0.341 0.464
900 1.000 1.000 1.000
Doctors
99 0.505 0.516 0.186 0.586 0.519 0.303 0.578 0.533 0.304
100–199 0.542 0.397 0.123 0.543 0.399 0.126 0.498 0.414 0.093
200–299 0.939 0.298 0.834 1.049 0.300 0.873 1.138 0.306 0.673
300 1.000 1.000 1.000
MRI
No 1.000 1.000 1.000
Yes 1.682 0.882 0.556 1.905 0.888 0.468 1.793 0.893 0.513
ient
ll b
TABLE 2. (Continued )
Medicine  Volume 95, Number 11, March 2016 Healthcare Technology and Qualityrates at hospitals with low healthcare technology were higher
than in those with high healthcare technology.
We also found that patients diagnosed with ischemic stroke
treated in hospitals with low healthcare technology, regardless
of the hospital volume of cerebrovascular surgical procedures,
had the highest 30-day mortality rate, followed by patients
diagnosed with ischemic stroke treated at middle healthcare
technology hospitals. Patients diagnosed with ischemic stroke
HR¼ hazard ratio, MRI¼magnetic resonance imaging, PCCL¼ pat
Operation of cerebral arteriovenous malformation, operation of skutreated at high healthcare technology hospitals had the lowest
30-day mortality rate, regardless of the hospital volume of
cerebrovascular surgical procedures; but the 30-day, all-cause
FIGURE 4. Adjusted association between hospital-based healthcare t
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.mortality rate in hospitals with low healthcare technology and
high hospital volume (low–high) was the highest.
The results of our study provide very insightful scientific
evidence into the association between hospital-based healthcare
technology and 30-day mortality following complex surgical
procedures. In this study, we addressed the notion that volume is
a predictor of mortality by showing the independent effect of
hospital-based healthcare technology, beyond hospital volume,
clinical complexity level, SE ¼ standard error.
ase, carotid artery ligation, and endoscopic brain surgery.on mortality.
Although hospital-based healthcare technology level pro-
vided a straightforward predictor for outcome, 1 argument
echnology and all-cause mortality (Model 3).
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TABLE 3. Adjusted Association Between Hospital-Based Healthcare Technology and All-Cause Mortality in Ischemic Stroke
Patients Admitted Through Emergency Room
30-d All-Cause Mortality
Model 1 Model 2 Model 3
HR SE P Value HR SE P Value HR SE P Value
Hospital-based healthcare technology
Low 2.289 0.368 0.024
Middle 1.479 0.264 0.139
High 1.000
Hospital volume of cerebrovascular surgery
Low 2.188 0.325 0.016 1.841 0.330 0.064
Middle 1.971 0.320 0.034 1.805 0.318 0.063
High 1.000 1.000
Hospital-based healthcare technology–hospital volume of cerebrovascular surgery
Low–low 6.051 0.555 0.001
Middle–low 4.798 0.469 0.001
High–low 2.140 0.508 0.134
Low–middle 1.221 1.065 0.852
Middle–middle 3.354 0.493 0.014
High–middle 3.676 0.447 0.004
Low–high 12.424 0.606 <0.0001
Middle–high 1.668 0.546 0.348
High–high 1.000
Kim et al Medicine  Volume 95, Number 11, March 2016against its use may be that hospital-based healthcare technology
is simply a proxy for size or volume. In fact, hospital-based
healthcare technology used for identifying these mechanisms
was correlated with size or volume. As in a previous study,13 our
Adjusted for all variables.
HR¼ hazard ratio, SE ¼ standard error.study showed that approximately 40% of the 539 hospitals in the
highest healthcare technology quintile were medium- or smal-
ler-sized hospitals; however, our results were far from identical
FIGURE 5. Adjusted association between hospital-based healthcare
admitted through emergency room (Model 3).
8 | www.md-journal.comto those in the other study.13 In addition, the hospital volume-to-
outcomes relationship remains controversial.14,15 Luft et al16
examined 2 hypotheses in their study. The first ‘‘selective
referral’’ hypothesis indicates possible reverse causality in
the volume–outcome relationship: physicians and hospitals
with improved patient outcomes attract higher volumes of
patients. The second ‘‘practice-makes-perfect’’ hypothesis is
technology and all-cause mortality in ischemic stroke patients
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
based on the mechanism of ‘‘learning by doing,’’ by which
providers achieve improved patient outcomes as a result of
increased expertise resulting from the increased volume. How-
ever, Huesch17 and Tsai et al18 concluded that learning and
selective referral effects played no significant role in the
volume–outcome relationship. That is, volume alone does
not result in improved patient outcomes.19,20 In addition, it
remains unclear whether volume always leads to improved
clinical judgment, better patient selection, or reduced technical
errors. Thus, there is considerable consensus that volume is an
imperfect correlate of healthcare quality given that availability
of new technologies and better management of health
resources, multidisciplinary discussions, etc., have improved
considerably.
It is also clear that, as hospitals or surgeons perform
cerebrovascular surgical procedures with high levels of health-
care technology, they can reduce their patients’ mortality rates.
It is also possible that these high levels of healthcare technol-
ogies may relate to the well selected teams of healthcare
providers with advanced training programs, including nursing
staff who are brought together by specialty-trained surgeons.
These highly trained providers can implement standardized
clinical pathways, protocols, and appropriate mechanisms to
provide proper treatment that might improve the safety of
cerebrovascular surgical procedures.
Therefore, although a hospital volume–mortality relation-
ship in cerebrovascular surgical procedures existed in our study
as in previous studies,21–26 this study serves as a reminder that
hospital-based healthcare technology is an important explana-
tory predictor underlying the relationship between hospital
volume and mortality. Thus, further research is necessary to
identify the key processes of quality of care in hospitals
performing cerebrovascular surgical procedures that impact
mortality. Such processes may include availability of sophis-
ticated services and quality improvement program such as
clinical pathways and protocols.
In addition, although high surgical techniques, and care
processes are essential for improving the care and outcomes of
surgical patients, the cost for developing and utilizing new
medical technologies is high.27 Actually, the United States
spent 2.9 trillion dollars on health care in 2013.27 This figure
continues to rise and has been a significant economic burden
with legislative efforts aimed at flattening the cost curve.
However, this is not necessarily bad as long as the new
technologies result in clear outcome improvements. In addition,
health outcomes/the costs defined as value28 are difficult to
actually measure when applied to surgical care and technologies
in healthcare domains due to the fact that its elements are
dynamic. Improved outcomes associated with changes in cost of
technology driven by competition and changes in market share
alter the equation over time.29 Therefore, further study will also
be essential in identifying the clinical domains in which health-
care technology is most beneficial, as well as investigating if
there is a relationship between healthcare technology and cost
of care.
Our study has a number of strengths and limitations. The
participants in the survey are representative of the overall South
Korean cerebrovascular inpatient population. Our large and
longitudinal cohort sample size allowed the results to be
generalized to the adult South Korean population. Nevertheless,
several limitations that may have affected our results need to be
Medicine  Volume 95, Number 11, March 2016considered in the interpretation of our findings. First, when
we selected participants for our study, both ICD coding
and cerebrovascular surgical patient characteristics were
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.considered. However, because the categorization of hospital-
based healthcare technology relied on ICD coding of principal
diagnosis, it is difficult to validate individual ICD codes. Our
data are from a deidentified database, making it susceptible to
errors related to coding. Second, as this is a large and longi-
tudinal nationwide sample, there may be significant heterogen-
eity in the care provided both in the field and at receiving
hospitals. Thus, we cannot comment on which aspects of patient
care most affected survival. Third, although unmeasured hos-
pital characteristics, such as the availability and quality of
protocols used, may contribute to outcomes, we could not
analyze the contribution of these hospital characteristics
because of the limited information in the claims database.
Finally, in this study, although specialty hospitals dedicated
to a narrow range of procedures, but may in fact be institutions
with high healthcare technology, we could not excluded speci-
alty hospitals due to lack of information. Nevertheless, although
this limits the generalizability of our study, the majority of
participants still take place in general hospitals.
CONCLUSION
This study provides scientific evidence suggesting that
hospital-based healthcare technology is the most important
variable underlying the relationship between hospital volume
and mortality. Volume alone is an imperfect correlate for
quality. Higher levels of hospital-based healthcare technology
have a strong association, independent of hospital volume, with
decreased mortality. Therefore, further research to identify the
key components of technology that affect mortality is warranted
because the evidence in this area is lacking.
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